TrioMRR
A browser-based review-to-report workspace for consultant pharmacists
TrioMRR keeps review context, structured recommendations, outcomes, and facility-facing reports in one shared system. Its public story is strongest around straightforward MRR work, reusable reporting, team continuity, and migration from RxPertise.
What the public record says
TrioMRR starts with the work consultant pharmacists repeat each month: review the resident context, record a recommendation with useful structure, follow the response, and turn the same work into reports for different audiences. The product page describes monthly, admission, and interim review contexts rather than presenting the system as a generic note editor.
For a small practice, the practical appeal is continuity. The public site describes browser access, no local installation, centralized records, reusable report profiles, and the ability to reassign a facility when another consultant covers vacation or turnover. Those details matter more to a two-person shop than a long list of enterprise acronyms.
Its public integration story is much thinner than the workflow story. TrioMRR advertises direct conversion of RxPertise data, but the reviewed pages do not name live dispensing, EHR, eMAR, HIE, or laboratory interfaces. Buyers should separate a one-time conversion from an ongoing interface during the demo.
Evidence we found
One connected clinical loop
The vendor describes review, recommendation, outcomes tracking, and reporting as one connected workflow, with structured category, routing, physician-audience, and task information carried with each recommendation.
Reports for several audiences
Publicly listed outputs include executive summaries, multiple MRR layouts, outcomes follow-up, psychotropic utilization, recommendation data, resident lists, and psychotropic-order views. Report profiles can be saved and reused.
Shared browser-based records
The vendor states that authorized pharmacists work from one centralized database on any device or operating system, with automatic updates and backups and without teammate-to-teammate file transfers.
RxPertise transition path
TrioMRR offers a 30-day trial using converted RxPertise data and says a BAA is executed before protected health information is imported.
Where a buyer should slow down
No named live clinical-data connector
The reviewed public pages do not identify a live dispensing, eMAR, EHR, HIE, or lab connection. Ask the vendor to demonstrate the exact import or interface used with each pharmacy and facility in your book of business.
Be precise about saved reporting
The site supports reusable report profiles, but that should not be read as proof that every saved report is a locked, historically frozen clinical artifact. Confirm how released reports, revisions, and source data are retained.
Treat compliance language as a vendor statement
TrioMRR describes encryption, access controls, backups, and HIPAA-oriented handling. Buyers still need the BAA, security documentation, incident terms, audit evidence, and their own compliance review before using real PHI.
Fit by operating model
One- and two-person practice
A focused shortlist candidate for one- and two-pharmacist practices.
- The vendor explicitly addresses solo practitioners as well as groups.
- Browser access and centralized records remove local installation and teammate file handoffs.
- Reusable recommendations and report profiles target work repeated every review cycle.
Validate: The $200 monthly price is an exclusive, publisher-supplied offer rather than a publicly listed vendor price. · Confirm setup effort and the continuing data-refresh process for every facility. · Ask how data is exported if the practice later changes systems.
Larger organization
Team foundations are public; enterprise depth needs a procurement review.
- The shared database and facility reassignment support multi-consultant continuity.
- Several report layouts and organization-wide consistency are part of the product story.
Validate: Verify SSO, MFA policy, audit exports, user lifecycle controls, SLAs, and disaster-recovery evidence. · Ask for named production interfaces and migration experience at comparable scale. · Confirm whether cross-facility operational dashboards meet leadership needs beyond report generation.
Questions to take to the demo
- Show us exactly how medication, census, and lab data arrive each month. A smooth review screen does not eliminate work if the source data still needs extensive manual preparation.
- Is a released report stored as an immutable snapshot, and how are corrections recorded? Reusable profiles and report history are different from a defensible record of what a facility received.
- Which controls, logs, and security documents can you provide before our pilot? Healthcare buyers should evaluate evidence and contract terms, not rely on a marketing compliance label.
- What is included in conversion, onboarding, support, and data export? The real first-year cost includes the transition and the work required to leave, not only the seat fee.
Public comparison detail
LTC MRR
Yes — purpose-built
The public product is organized around consultant-pharmacist medication regimen review in long-term care.
Buyer prompt: Is the workflow designed around recurring consultant-pharmacist review?
Deployment
Cloud / browser
The vendor states that the product runs in a browser on computers, tablets, and mobile devices with no local installation.
Buyer prompt: Is it browser-based, installed, or dependent on another pharmacy platform?
Reviews
Monthly, admission, and interim context
The public workflow describes monthly, admission, and interim MRR context.
Buyer prompt: Which monthly, admission, interim, and other review types are publicized?
Recommendations
Structured recommendations and reusable content
Recommendations can carry category, routing, physician audience, and task information; reporting profiles can be reused.
Buyer prompt: How does the product create, reuse, route, and standardize recommendations?
Follow-up
Outcomes and pending follow-up
The site describes outcomes tracking and a pending-outcomes reporting workflow.
Buyer prompt: Can pharmacists record responses and find recommendations still awaiting action?
Psych / GDR
Psychotropic review and reporting
The vendor describes psychotropic considerations, psychotropic orders, utilization views, and optional CASPER reference data. Public pages do not establish a complete benchmark methodology.
Buyer prompt: What medication-use and gradual dose reduction support is publicly described?
Analytics
Report-based operational views
Executive, recommendation-data, outcomes, and psychotropic reports are public. A live firm-wide QAPI command center is not described.
Buyer prompt: Can leaders see trends beyond one resident or one report packet?
Integrations
RxPertise conversion publicized
Direct RxPertise conversion is publicized; no named live dispensing, EHR, eMAR, HIE, or lab connector was found on the reviewed pages.
Buyer prompt: Which dispensing, EHR, eMAR, HIE, and lab connections are actually identified?
Reporting
Seven report types and multiple layouts
Reports target leadership, prescribers, nursing, and operations, with reusable profiles and multiple resident-level layouts.
Buyer prompt: Which report audiences, formats, routing, and delivery methods are described?
Collaboration
Shared database and coverage reassignment
The vendor describes one source of truth for the team and reassignment when consultants cover another facility.
Buyer prompt: How does work move between pharmacists, facilities, and prescribers?
Controls
Role-based access stated
The privacy page states role-based access and activity logging. Scope, exportability, and independent assurance are not detailed publicly.
Buyer prompt: What role, activity-log, and administrative controls does the vendor state publicly?
Business tools
Not publicly specified
The reviewed pages do not describe time tracking, invoicing, medical claims, or client billing.
Buyer prompt: Does the public product include timekeeping, invoicing, claims, or client billing?